The Acron System is the brainchild of Christian Schawrda & Andeas Bernegger, co-founders of the SpineMed Group in Vienna (Austria) and Acron Medical LLC, in Orlando (Florida).
The technology was developed to address the needs of patients with osteoporosis in need of a spinal fusion. After 3 years of clinical validation in Austria, Switzerland and Germany, the Acron System is now available in the United States.http://www.acron-medical.com
About the Spinal Market
The Spinal implants and spinal devices market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, and motion preservation/non-fusion technologies. On the basis of products, the global spinal implants and spinal devices market is divided into six major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, and spine bone stimulators. Bases on the type of surgery, the global spinal implants and spinal devices market is divided into two segments, namely, open surgery and minimally invasive surgery. The spinal decompression devices market, by type of procedure, covers discectomy, laminotomy/laminectomy, foraminotomy/foraminectomy, facetectomy, and corpectomy procedures.
The Spinal market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020. As of 2015, North America is estimated to hold the largest share of the global spinal implants and spinal devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2015 to 2020. A number of factors, including rising healthcare expenditure in developing nations owing to growing income levels, increasing government funding, presence of a large patient population, rising obesity cases, and growing awareness on the newly developed spine treatment techniques and devices are propelling the growth of the spinal implants and spinal devices market in the Asia-Pacific region. However, challenges associated with this market, such as scarcity of expertise and trained healthcare workers and lack of adequate patient awareness restricts the market growth in this region.Source: http://www.marketsandmarkets.com